BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 18599482)

  • 21. Co-chaperone CHIP promotes aggregation of ataxin-1.
    Choi JY; Ryu JH; Kim HS; Park SG; Bae KH; Kang S; Myung PK; Cho S; Park BC; Lee DH
    Mol Cell Neurosci; 2007 Jan; 34(1):69-79. PubMed ID: 17127076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SUMOylation of the polyglutamine repeat protein, ataxin-1, is dependent on a functional nuclear localization signal.
    Riley BE; Zoghbi HY; Orr HT
    J Biol Chem; 2005 Jun; 280(23):21942-8. PubMed ID: 15824120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquitination regulates the neuroprotective function of the deubiquitinase ataxin-3 in vivo.
    Tsou WL; Burr AA; Ouyang M; Blount JR; Scaglione KM; Todi SV
    J Biol Chem; 2013 Nov; 288(48):34460-9. PubMed ID: 24106274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Splice isoforms of the polyglutamine disease protein ataxin-3 exhibit similar enzymatic yet different aggregation properties.
    Harris GM; Dodelzon K; Gong L; Gonzalez-Alegre P; Paulson HL
    PLoS One; 2010 Oct; 5(10):e13695. PubMed ID: 21060878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity.
    Burnett B; Li F; Pittman RN
    Hum Mol Genet; 2003 Dec; 12(23):3195-205. PubMed ID: 14559776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Vps27/Hrs/STAM (VHS) Domain of the Signal-transducing Adaptor Molecule (STAM) Directs Associated Molecule with the SH3 Domain of STAM (AMSH) Specificity to Longer Ubiquitin Chains and Dictates the Position of Cleavage.
    Baiady N; Padala P; Mashahreh B; Cohen-Kfir E; Todd EA; Du Pont KE; Berndsen CE; Wiener R
    J Biol Chem; 2016 Jan; 291(4):2033-2042. PubMed ID: 26601948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NEDD8: a new ataxin-3 interactor.
    Ferro A; Carvalho AL; Teixeira-Castro A; Almeida C; Tomé RJ; Cortes L; Rodrigues AJ; Logarinho E; Sequeiros J; Macedo-Ribeiro S; Maciel P
    Biochim Biophys Acta; 2007 Nov; 1773(11):1619-27. PubMed ID: 17935801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein-linked ubiquitin chain structure restricts activity of deubiquitinating enzymes.
    Schaefer JB; Morgan DO
    J Biol Chem; 2011 Dec; 286(52):45186-96. PubMed ID: 22072716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and functional analysis of ataxin-2 and ataxin-3.
    Albrecht M; Golatta M; Wüllner U; Lengauer T
    Eur J Biochem; 2004 Aug; 271(15):3155-70. PubMed ID: 15265035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FAT10 protein binds to polyglutamine proteins and modulates their solubility.
    Nagashima Y; Kowa H; Tsuji S; Iwata A
    J Biol Chem; 2011 Aug; 286(34):29594-600. PubMed ID: 21757738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis for specific cleavage of Lys 63-linked polyubiquitin chains.
    Sato Y; Yoshikawa A; Yamagata A; Mimura H; Yamashita M; Ookata K; Nureki O; Iwai K; Komada M; Fukai S
    Nature; 2008 Sep; 455(7211):358-62. PubMed ID: 18758443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expanding SUMO and ubiquitin-mediated signaling through hybrid SUMO-ubiquitin chains and their receptors.
    Guzzo CM; Matunis MJ
    Cell Cycle; 2013 Apr; 12(7):1015-7. PubMed ID: 23511166
    [No Abstract]   [Full Text] [Related]  

  • 33. Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism.
    Warrick JM; Morabito LM; Bilen J; Gordesky-Gold B; Faust LZ; Paulson HL; Bonini NM
    Mol Cell; 2005 Apr; 18(1):37-48. PubMed ID: 15808507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Polyglutamine-expanded ataxin-3 is degraded by autophagy].
    Xiao H; Tang J; Hu Z; Tan J; Tang B; Jiang Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):23-8. PubMed ID: 20140862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis.
    Chai Y; Shao J; Miller VM; Williams A; Paulson HL
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9310-5. PubMed ID: 12084819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Involvement of ubiquitin-proteasome system in polyglutamine disease].
    Matsumoto M
    Tanpakushitsu Kakusan Koso; 2006 Aug; 51(10 Suppl):1428-32. PubMed ID: 16922413
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3.
    Masino L; Nicastro G; Menon RP; Dal Piaz F; Calder L; Pastore A
    J Mol Biol; 2004 Dec; 344(4):1021-35. PubMed ID: 15544810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Josephin domain-containing proteins from a variety of species are active de-ubiquitination enzymes.
    Tzvetkov N; Breuer P
    Biol Chem; 2007 Sep; 388(9):973-8. PubMed ID: 17696782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation.
    Evert BO; Araujo J; Vieira-Saecker AM; de Vos RA; Harendza S; Klockgether T; Wüllner U
    J Neurosci; 2006 Nov; 26(44):11474-86. PubMed ID: 17079677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. USP7, a ubiquitin-specific protease, interacts with ataxin-1, the SCA1 gene product.
    Hong S; Kim SJ; Ka S; Choi I; Kang S
    Mol Cell Neurosci; 2002 Jun; 20(2):298-306. PubMed ID: 12093161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.